DNA methylation-based reclassification of olfactory neuroblastoma

被引:0
|
作者
David Capper
Nils W. Engel
Damian Stichel
Matt Lechner
Stefanie Glöss
Simone Schmid
Christian Koelsche
Daniel Schrimpf
Judith Niesen
Annika K. Wefers
David T. W. Jones
Martin Sill
Oliver Weigert
Keith L. Ligon
Adriana Olar
Arend Koch
Martin Forster
Sebastian Moran
Oscar M. Tirado
Miguel Sáinz-Jaspeado
Jaume Mora
Manel Esteller
Javier Alonso
Xavier Garcia del Muro
Werner Paulus
Jörg Felsberg
Guido Reifenberger
Markus Glatzel
Stephan Frank
Camelia M. Monoranu
Valerie J. Lund
Andreas von Deimling
Stefan Pfister
Rolf Buslei
Julika Ribbat-Idel
Sven Perner
Volker Gudziol
Matthias Meinhardt
Ulrich Schüller
机构
[1] German Cancer Consortium (DKTK),Clinical Cooperation Unit Neuropathology
[2] German Cancer Research Center (DKFZ),Department of Neuropathology
[3] University Hospital Heidelberg,Center for Neuropathology
[4] Ludwig-Maximilians-University,Department of Oncology and Hematology with Sections Bone Marrow Transplant and Pneumology
[5] Hubertus Wald Tumorzentrum/University Cancer Center Hamburg,Royal National Throat, Nose and Ear Hospital
[6] University Medical Center Hamburg,UCL Cancer Institute
[7] University College London Hospitals NHS Trust,Head and Neck Centre
[8] University College London,Division of Pediatric Neurooncology
[9] University College London Hospitals NHS Trust,Department of Internal Medicine III
[10] Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ),Department of Medical Oncology and Center for Molecular Oncologic Pathology
[11] German Cancer Consortium (DKTK),Departments of Pathology and Laboratory Medicine and Neurosurgery
[12] German Cancer Research Center (DKFZ),Institute of Neuropathology
[13] University Hospital of the Ludwig-Maximilians-University Munich,Institute of Neuropathology
[14] Dana-Farber/Brigham and Women’s Cancer Center,Medical Faculty, Institute of Neuropathology
[15] Harvard Medical School,Institute of Neuropathology
[16] Medical University of South Carolina and Hollings Cancer Center,Department of Pathology
[17] Charité-Universitätsmedizin Berlin,Institute of Pathology
[18] Freie Universität Berlin,Department of Neuropathology
[19] Humboldt-Universität zu Berlin,Institute of Pathology
[20] Berlin Institute of Health,ENT Department
[21] German Cancer Consortium (DKTK),Institute for Pathology
[22] Partner Site Berlin,Department of Pediatric Hematology and Oncology
[23] University Hospital Münster,Department of Pediatric Oncology, Hematology and Immunology
[24] Heinrich Heine University,Cancer Epigenetics and Biology Program (PEBC)
[25] German Cancer Consortium (DKTK),Sarcoma Research Group, Molecular Oncology Lab
[26] Partner Site Essen/Düsseldorf,Department of Pediatric Onco
[27] University Medical Center Hamburg,Hematology and Developmental Tumor Biology Laboratory
[28] Universitätsspital Basel,Department of Physiological Sciences II, School of Medicine
[29] Julius-Maximilians-University,Pediatric Solid Tumor Laboratory, Human Genetic Department
[30] University of Erlangen,Oncology Department
[31] University Hospital Bonn,Institute of Pathology/Neuropathology
[32] Universitätsklinikum Carl Gustav Carus Dresden,Pathology
[33] Universitätsklinikum Carl Gustav Carus Dresden,undefined
[34] University Medical Center,undefined
[35] Research Institute Children’s Cancer Center Hamburg,undefined
[36] Heidelberg University Hospital,undefined
[37] Bellvitge Biomedical Research Institute (IDIBELL),undefined
[38] Bellvitge Biomedical Research Institute (IDIBELL),undefined
[39] Hospital Sant Joan de Déu,undefined
[40] University of Barcelona,undefined
[41] Institucio Catalana de Recerca i Estudis Avançats (ICREA),undefined
[42] Research Institute of Rare Diseases,undefined
[43] Instituto de Salud Carlos III,undefined
[44] ICO-IDIBELL,undefined
[45] Klinikum am Bruderwald,undefined
[46] Sozialstiftung Bamberg,undefined
[47] University Hospital Schleswig-Holstein,undefined
[48] Research Center Borstel,undefined
[49] Leibniz Center for Medicine and Biosciences,undefined
来源
Acta Neuropathologica | 2018年 / 136卷
关键词
Esthesioneuroblastoma; CpG Island Methylator Phenotype (CIMP); IDH1 Mutation; Sinonasal Adenocarcinoma; Sinonasal Tumors;
D O I
暂无
中图分类号
学科分类号
摘要
Olfactory neuroblastoma/esthesioneuroblastoma (ONB) is an uncommon neuroectodermal neoplasm thought to arise from the olfactory epithelium. Little is known about its molecular pathogenesis. For this study, a retrospective cohort of n = 66 tumor samples with the institutional diagnosis of ONB was analyzed by immunohistochemistry, genome-wide DNA methylation profiling, copy number analysis, and in a subset, next-generation panel sequencing of 560 tumor-associated genes. DNA methylation profiles were compared to those of relevant differential diagnoses of ONB. Unsupervised hierarchical clustering analysis of DNA methylation data revealed four subgroups among institutionally diagnosed ONB. The largest group (n = 42, 64%, Core ONB) presented with classical ONB histology and no overlap with other classes upon methylation profiling-based t-distributed stochastic neighbor embedding (t-SNE) analysis. A second DNA methylation group (n = 7, 11%) with CpG island methylator phenotype (CIMP) consisted of cases with strong expression of cytokeratin, no or scarce chromogranin A expression and IDH2 hotspot mutation in all cases. T-SNE analysis clustered these cases together with sinonasal carcinoma with IDH2 mutation. Four cases (6%) formed a small group characterized by an overall high level of DNA methylation, but without CIMP. The fourth group consisted of 13 cases that had heterogeneous DNA methylation profiles and strong cytokeratin expression in most cases. In t-SNE analysis, these cases mostly grouped among sinonasal adenocarcinoma, squamous cell carcinoma, and undifferentiated carcinoma. Copy number analysis indicated highly recurrent chromosomal changes among Core ONB with a high frequency of combined loss of chromosome 1–4, 8–10, and 12. NGS sequencing did not reveal highly recurrent mutations in ONB, with the only recurrently mutated genes being TP53 and DNMT3A. In conclusion, we demonstrate that institutionally diagnosed ONB are a heterogeneous group of tumors. Expression of cytokeratin, chromogranin A, the mutational status of IDH2 as well as DNA methylation patterns may greatly aid in the precise classification of ONB.
引用
收藏
页码:255 / 271
页数:16
相关论文
共 50 条
  • [1] DNA methylation-based reclassification of olfactory neuroblastoma
    Capper, David
    Engel, Nils W.
    Stichel, Damian
    Lechner, Matt
    Gloess, Stefanie
    Schmid, Simone
    Koelsche, Christian
    Schrimpf, Daniel
    Niesen, Judith
    Wefers, Annika K.
    Jones, David T. W.
    Sill, Martin
    Weigert, Oliver
    Ligon, Keith L.
    Olar, Adriana
    Koch, Arend
    Forster, Martin
    Moran, Sebastian
    Tirado, Oscar M.
    Sainz-Jaspeado, Miguel
    Mora, Jaume
    Esteller, Manel
    Alonso, Javier
    Garcia del Muro, Xavier
    Paulus, Werner
    Felsberg, Joerg
    Reifenberger, Guido
    Glatzel, Markus
    Frank, Stephan
    Monoranu, Camelia M.
    Lund, Valerie J.
    von Deimling, Andreas
    Pfister, Stefan
    Buslei, Rolf
    Ribbat-Idel, Julika
    Perner, Sven
    Gudziol, Volker
    Meinhardt, Matthias
    Schueller, Ulrich
    ACTA NEUROPATHOLOGICA, 2018, 136 (02) : 255 - 271
  • [2] Correction to: DNA methylation-based reclassification of olfactory neuroblastoma
    David Capper
    Nils W. Engel
    Damian Stichel
    Matt Lechner
    Stefanie Glöss
    Simone Schmid
    Christian Kölsche
    Daniel Schrimpf
    Judith Niesen
    Annika K. Wefers
    David T. W. Jones
    Martin Sill
    Oliver Weigert
    Keith L. Ligon
    Adriana Olar
    Arend Koch
    Martin Forster
    Sebastian Moran
    Oscar M. Tirado
    Miguel Sáinz-Jaspeado
    Jaume Mora
    Manel Esteller
    Javier Alonso
    Xavier Garcia del Muro
    Werner Paulus
    Jörg Felsberg
    Guido Reifenberger
    Markus Glatzel
    Stephan Frank
    Camelia M. Monoranu
    Valerie J. Lund
    Andreas von Deimling
    Stefan Pfister
    Rolf Buslei
    Julika Ribbat-Idel
    Sven Perner
    Volker Gudziol
    Matthias Meinhardt
    Ulrich Schüller
    Acta Neuropathologica, 2018, 136 : 505 - 505
  • [3] DNA methylation-based reclassification of olfactory neuroblastoma (vol 136, pg 255, 2018)
    Capper, David
    Engel, Nils W.
    Stichel, Damian
    Lechner, Matt
    Gloess, Stefanie
    Schmid, Simone
    Koelsche, Christian
    Schrimpf, Daniel
    Niesen, Judith
    Wefers, Annika K.
    Jones, David T. W.
    Sill, Martin
    Weigert, Oliver
    Ligon, Keith L.
    Olar, Adriana
    Koch, Arend
    Forster, Martin
    Moran, Sebastian
    Tirado, Oscar M.
    Sainz-Jaspeado, Miguel
    Mora, Jaume
    Esteller, Manel
    Alonso, Javier
    del Muro, Xavier Garcia
    Paulus, Werner
    Felsberg, Joerg
    Reifenberger, Guido
    Glatzel, Markus
    Frank, Stephan
    Monoranu, Camelia M.
    Lund, Valerie J.
    von Deimling, Andreas
    Pfister, Stefan
    Buslei, Rolf
    Ribbat-Idel, Julika
    Perner, Sven
    Gudziol, Volker
    Meinhardt, Matthias
    Schueller, Ulrich
    ACTA NEUROPATHOLOGICA, 2018, 136 (03) : 505 - 505
  • [4] DNA Methylation-Based Biomarkers
    Cerchietti, Leandro
    Melnick, Ari
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 793 - 795
  • [5] A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes
    Luo, Qizhan
    Vogeli, Thomas-Alexander
    CANCERS, 2020, 12 (10) : 1 - 21
  • [6] Methylation-based reclassification and risk stratification of skull-base chordomas
    Huo, Xulei
    Guo, Tengxian
    Wang, Ke
    Yao, Bohan
    Li, Da
    Li, Huan
    Chen, Wei
    Wang, Liang
    Wu, Zhen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] DNA methylation-based biomarkers in bladder cancer
    Raju Kandimalla
    Angela A. van Tilborg
    Ellen C. Zwarthoff
    Nature Reviews Urology, 2013, 10 : 327 - 335
  • [8] DNA methylation-based biomarkers in urological cancers
    Xu, Rong
    Lin, Shaokun
    Xin, Jun
    Guo, Youhong
    Zhang, Wenzhou
    Lin, Yangjun
    Xu, Rui'an
    Information Technology Journal, 2013, 12 (17) : 4289 - 4297
  • [9] DNA methylation-based biomarkers in bladder cancer
    Kandimalla, Raju
    van Tilborg, Angela A.
    Zwarthoff, Ellen C.
    NATURE REVIEWS UROLOGY, 2013, 10 (06) : 327 - 335
  • [10] Developing DNA methylation-based diagnostic biomarkers
    Hyerim Kim
    Xudong Wang
    Peng Jin
    Journal of Genetics and Genomics, 2018, 45 (02) : 87 - 97